NEW YORK, September 21, 2015 /PRNewswire/ --
Equity Research Institute has initiated coverage on the
following equities: Hologic Inc. (NASDAQ: HOLX), Amedica
Corporation (NASDAQ: AMDA), St. Jude Medical Inc. (NYSE: STJ),
MiMedx Group Inc. (NASDAQ: MDXG) and Zimmer Biomet Holdings Inc.
(NYSE: ZBH). Free research report on Hologic can be accessed at
https://www.erionline.net/HOLX.pdf. On Friday, September 18, 2015, the NASDAQ Composite
ended at 4,827.23, down 1.36%, the Dow Jones Industrial Average
declined 1.74%, to finish the day at 16,384.79 and the S&P 500
closed at 1,958.03, down 1.62%. The losses were broad based as
eight out of nine sectors ended the session in negative. Register
for your complimentary reports at the links given below.
Hologic Inc.'s stock edged 0.90% lower, to close the day at
$41.61. The stock recorded a trading
volume of 5.64 million shares, above its three months average
volume of 3.24 million shares. Over the previous three months and
since the start of this year, Hologic Inc.'s shares have surged
8.76% and 55.61%, respectively. However, the stock has lost 1.42%
in the last one month. The company's shares are trading 4.80% and
22.16% above their 50-day and 200-day moving averages,
respectively. Additionally, Hologic Inc. traded at a PE ratio of
88.53 and has a Relative Strength Index (RSI) of 60.60. Sign up and
read the free notes on HOLX at:
https://www.erionline.net/HOLX.pdf
On Friday, shares in Amedica Corp. recorded a trading volume of
0.82 million shares, lower than their three months average volume
of 3.32 million shares. The stock ended the day 4.02% higher at
$0.44. Amedica Corp.'s stock has lost
9.54% in the last one month, 19.09% in the previous three months
and 45.39% on YTD basis. The company is trading below its 50-day
and 200-day moving averages by 13.76% and 17.29%, respectively.
Furthermore, shares of Amedica Corp. have an RSI of 46.50. The
complimentary notes on AMDA can be downloaded in PDF format at:
https://www.erionline.net/AMDA.pdf
St. Jude Medical Inc.'s stock lost 2.79%, to close Friday's
session at $67.31. The stock recorded
a trading volume of 3.14 million shares, above its three months
average volume of 1.74 million shares. Over the last one month and
the previous three months, St. Jude Medical Inc.'s shares have
declined 6.70% and 10.69%, respectively. However, the stock has
gained 4.37% since the start of this year. The company is trading
6.85% and 3.36% below its 50-day and 200-day moving averages,
respectively. Furthermore, St. Jude Medical Inc.'s stock traded at
a PE ratio of 18.75 and has an RSI of 38.74. Register for free on
Equity Research Institute and access the latest research on STJ
at:
https://www.erionline.net/STJ.pdf
MiMedx Group Inc.'s stock finished Friday's session 1.19% higher
at $11.07. A total of 1.93 million
shares were traded, which was above its three months average volume
of 1.66 million shares. Over the last one month and the previous
three months, MiMedx Group Inc.'s shares have gained 18.90% and
0.45%, respectively. However, the stock has lost 3.99% since the
beginning of 2015. The company's shares are trading above their
50-day and 200-day moving averages by 4.54% and 8.70%,
respectively. MiMedx Group Inc.'s stock traded at a PE ratio of
73.80 and has an RSI of 60.94. The complete research on MDXG is
available for free at:
https://www.erionline.net/MDXG.pdf
On Friday, shares in Zimmer Biomet Holdings Inc. ended the
session 1.68% lower at $99.20. The
stock reported a trading volume of 1.62 million shares, above its
three months average volume of 1.36 million shares. Shares of the
company traded at a PE ratio of 50.10. Zimmer Biomet Holdings
Inc.'s shares have declined 6.54% in the last one month, 11.95% in
the previous three months and 12.20% on YTD basis. The company is
trading 4.65% below its 50-day moving average and 11.56% below its
200-day moving average. Moreover, shares of Zimmer Biomet Holdings
Inc. have an RSI of 40.08. Free in-depth research on ZBH is
available at:
https://www.erionline.net/ZBH.pdf
--
About Equity Research Institute:
Equity Research Institute ("ERI") produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. ERI has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ERI has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on sound investment judgment and publicly
available information which is believed to be reliable. The
Reviewer and the Sponsor have not performed any independent
investigations or forensic audits to validate the information
herein. Unless otherwise noted, any content outside of this
document has no association with the Author, the Reviewer, or the
Sponsor (collectively referred to as the "Production Team") in any
way. The Production Team is compensated on a fixed monthly basis
and do not hold any positions of interest in any of the securities
mentioned herein.
NO WARRANTY
ERI, the Author, the Reviewer and the Sponsor (collectively
referred to as the "Publishers") are not responsible for any error
which may be occasioned at the time of printing of this document or
any error, mistake or shortcoming. No liability is accepted by the
Publishers whatsoever for any direct, indirect or consequential
loss arising from the use of this document. The Publishers
expressly disclaim any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance
placed on the information in this document. Additionally, the
Publishers do not (1) guarantee the accuracy, timeliness,
completeness or correct sequencing of the information, or (2)
warrant any results from use of the information. The included
information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ERI nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://www.erionline.net.
RESTRICTIONS
ERI is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.erionline.net